Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Abera Bioscience

6.30 SEK

+0.80 %

Less than 1K followers

ABERA

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.80 %
-3.82 %
-7.35 %
-4.55 %
-19.75 %
+6.78 %
+35.19 %
-47.50 %
-42.99 %

Abera Bioscience operates in biotechnology. The company specializes in the development of vaccines based on a proprietary and patented platform. The technology is mainly used in the development of new vaccines, with a focus on the main areas of pneumococci and immuno-oncology. The operations are located throughout the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Read more
Market cap
129.14M SEK
Turnover
5.45K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.5
2026

Interim report Q1'26

10.6
2026

General meeting '26

20.8
2026

Interim report Q2'26

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.